Sekar A, Inverardi N, Lekkala S, Thomson A, Daesety V, Trendafilova D
Bioengineering (Basel). 2025; 12(2).
PMID: 40001692
PMC: 11851508.
DOI: 10.3390/bioengineering12020173.
Kim Y, Maric I, Kashiwagi C, Han L, Chung P, Reiss J
medRxiv. 2025; .
PMID: 39990567
PMC: 11844599.
DOI: 10.1101/2025.02.13.25322242.
Shpigler A, Kolet N, Golan S, Weisbart E, Zaritsky A
bioRxiv. 2024; .
PMID: 38895267
PMC: 11185510.
DOI: 10.1101/2024.06.01.595856.
Vitale G, Geibel C, Minda V, Wang M, Aron A, Petras D
Nat Prod Rep. 2024; 41(6):885-904.
PMID: 38351834
PMC: 11186733.
DOI: 10.1039/d3np00050h.
Albassam H, Ladin D, Elhassanny A, Burns C, Van Dross-Anderson R
Front Pharmacol. 2023; 14:1283677.
PMID: 38026967
PMC: 10652392.
DOI: 10.3389/fphar.2023.1283677.
α,α-disubstituted β-amino amides eliminate biofilms by membrane disruption and biomass removal.
Ausbacher D, Miller L, Goeres D, Stewart P, Strom M, Fallarero A
Biofilm. 2023; 6:100151.
PMID: 37662850
PMC: 10474319.
DOI: 10.1016/j.bioflm.2023.100151.
Benchmarking causal reasoning algorithms for gene expression-based compound mechanism of action analysis.
Hosseini-Gerami L, Alonzo Higgins I, Collier D, Laing E, Evans D, Broughton H
BMC Bioinformatics. 2023; 24(1):154.
PMID: 37072707
PMC: 10111792.
DOI: 10.1186/s12859-023-05277-1.
How Carvedilol activates β-adrenoceptors.
Benkel T, Zimmermann M, Zeiner J, Bravo S, Merten N, Lim V
Nat Commun. 2022; 13(1):7109.
PMID: 36402762
PMC: 9675828.
DOI: 10.1038/s41467-022-34765-w.
Quantifying the transport of biologics across intestinal barrier models in real-time by fluorescent imaging.
Weller A, Hansen M, Marie R, Hundahl A, Hempel C, Kempen P
Front Bioeng Biotechnol. 2022; 10:965200.
PMID: 36159696
PMC: 9500407.
DOI: 10.3389/fbioe.2022.965200.
Recent Advances Regarding the Molecular Mechanisms of Triterpenic Acids: A Review (Part I).
Mioc M, Milan A, Malita D, Mioc A, Prodea A, Racoviceanu R
Int J Mol Sci. 2022; 23(14).
PMID: 35887090
PMC: 9322890.
DOI: 10.3390/ijms23147740.
A Polymer-Based Multichannel Sensor for Rapid Cell-Based Screening of Antibiotic Mechanisms and Resistance Development.
Basu Roy S, Nabawy A, Chattopadhyay A, Geng Y, Makabenta J, Gupta A
ACS Appl Mater Interfaces. 2022; .
PMID: 35638721
PMC: 10587897.
DOI: 10.1021/acsami.2c07012.
The interactions between DNA nanostructures and cells: A critical overview from a cell biology perspective.
Frtus A, Smolkova B, Uzhytchak M, Lunova M, Jirsa M, Henry S
Acta Biomater. 2022; 146:10-22.
PMID: 35523414
PMC: 9590281.
DOI: 10.1016/j.actbio.2022.04.046.
Elucidating the Mechanisms of Action of Antimicrobial Agents.
Hudson M, Lockless S
mBio. 2022; 13(3):e0224021.
PMID: 35435702
PMC: 9239108.
DOI: 10.1128/mbio.02240-21.
Computational analyses of mechanism of action (MoA): data, methods and integration.
Trapotsi M, Hosseini-Gerami L, Bender A
RSC Chem Biol. 2022; 3(2):170-200.
PMID: 35360890
PMC: 8827085.
DOI: 10.1039/d1cb00069a.
Chemoproteomic-enabled characterization of small GTPase Rab1a as a target of an -arylbenzimidazole ligand's rescue of Parkinson's-associated cell toxicity.
Hatstat A, Quan B, Bailey M, Fitzgerald M, Reinhart M, McCafferty D
RSC Chem Biol. 2022; 3(1):96-111.
PMID: 35128413
PMC: 8729260.
DOI: 10.1039/d1cb00103e.
Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities.
Claridge B, Lozano J, Poh Q, Greening D
Front Cell Dev Biol. 2021; 9:734720.
PMID: 34616741
PMC: 8488228.
DOI: 10.3389/fcell.2021.734720.
Imaging therapeutic peptide transport across intestinal barriers.
Larsen J, Taebnia N, Dolatshahi-Pirouz A, Eriksen A, Hjorringgaard C, Kristensen K
RSC Chem Biol. 2021; 2(4):1115-1143.
PMID: 34458827
PMC: 8341777.
DOI: 10.1039/d1cb00024a.
Predicting mechanism of action of novel compounds using compound structure and transcriptomic signature coembedding.
Jang G, Park S, Lee S, Kim S, Park S, Kang J
Bioinformatics. 2021; 37(Suppl_1):i376-i382.
PMID: 34252937
PMC: 8275331.
DOI: 10.1093/bioinformatics/btab275.
Remdesivir for the treatment of Covid-19: the value of biochemical studies.
Gotte M
Curr Opin Virol. 2021; 49:81-85.
PMID: 34052732
PMC: 8114811.
DOI: 10.1016/j.coviro.2021.04.014.
Peptide-tiling screens of cancer drivers reveal oncogenic protein domains and associated peptide inhibitors.
Ford K, Panwala R, Chen D, Portell A, Palmer N, Mali P
Cell Syst. 2021; 12(7):716-732.e7.
PMID: 34051140
PMC: 8298269.
DOI: 10.1016/j.cels.2021.05.002.
